G
o
o
g
l
e
×
Please click
here
if you are not redirected within a few seconds.
All
Images
Videos
News
Maps
Shopping
Books
Search tools
Past hour
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Clear
FS118 Showcases Modest Efficacy in Relapsed/Refractory DLBCL
OncLive
FS118, an investigational LAG-3/PD-L1 bispecific antibody, demonstrated an encouraging objective response rate in the relapsed/refractory DLBCL setting.
14 minutes ago
